ORPHA:3355
Trichoodontoonychial dysplasia
Also known as: Trichoodontoonychial dysplasia with bone deficiency in frontoparietal region
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
33
32th percentile
Trials
0
Interventional, condition-specific
Researchers
192
Distinct authors in sample
Gene link
—
Readiness
1/6
Stages with a signal
Clinical definition (Orphanet)
Trichoodontoonychial is a rare ectodermal syndrome characterized by severe generalized hypotrichosis, parietal alopecia, secondary anodontia resulting from enamel hypoplasia, onychodystrophy, bone deficiency in the frontoparietal region and skin manifestations (incl. nevus pigmentosus, papules, ephelides, palmoplantar keratosis, supernumerary nipples, abnormal dermatoglyphics). There have been no further descriptions in the literature since 1983.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0010153
- MeSH:C564760
- OMIM:275450
- UMLS:C3279457
Additional Mondo synonyms (1)
trichoodontoonychial dysplasia with bone deficiency in frontoparietal region
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
1/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
33 matched papers (14 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
33
33 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
33 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
14 in the last 10 years · high confidence · 32th percentile (publications denominator)
Phrase hits: 33 · MeSH hits: 0
Who's working on it?
192
Distinct author names in 33 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Abdullah A1 paper · 2023
Division of Orthopaedic and Traumatology, Department of Surgery, Persahabatan General Hospital, Jakarta, Indonesia.
Papers in Europe PMC - 02Acevedo AC1 paper · 2023
Laboratory of Oral Histopathology, Oral Care Center for Inherited Diseases, Health Sciences Faculty, University of Brasilia, Brasilia 70040-010, Brazil.
Papers in Europe PMC - 03Agrawal KU1 paper · 2022
Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, 14th Floor, Philadelphia, PA, 19107, USA.
Papers in Europe PMC - 04Ali SR1 paper · 2021
Internal Medicine, Dow University of Health Sciences, Civil Hospital Karachi, Karachi, PAK.
Papers in Europe PMC - 05Anvekar P1 paper · 2021
Pediatrics, Mahatma Gandhi Mission Medical College and Hospital, Mumbai, IND.
Papers in Europe PMC - 06Arsenic R1 paper · 2013
Institute of Pathology, Cantonal Hospital Aarau, Aarau, Switzerland. ruza.arsenic@charite.de
Papers in Europe PMC - 07Avillach P1 paper · 2024
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA. Paul_Avillach@hms.harvard.edu.
Papers in Europe PMC - 08Bara-Casaus J1 paper · 2025
Department of Oral and Maxillofacial Surgery, Hospital Univeritari Mutua Terrassa, 08221 Barcelona, Spain.
Papers in Europe PMC - 09Baruchin AM1 paper · 1986Papers in Europe PMC
- 10Batory I1 paper · 1982Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Trichoodontoonychial dysplasia" OR "Trichoodontoonychial dysplasia with bone deficiency in frontoparietal region"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Trichoodontoonychial dysplasia" OR "Trichoodontoonychial dysplasia with bone deficiency in frontoparietal region" OR "ectodermal dysplasia syndrome"
Recall-expansion terms: ectodermal dysplasia syndrome
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T22:58:42.263Z